What would you like us to do with the funds you've selected
Change Share Class?
Show group factsheets
Download factsheet PDF
Buy this fund via Trustnet Direct
Add to Basket
Follow this fund on
To invest in the global healthcare sector with the objective of achieving a high level of capital growth. In order to achieve its investment objective, the Company invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing and derivative transactions to mitigate risk and also to enhance returns.
Samuel D Isaly Since 01-Apr-1995
Samuel D. Isaly has been active in international and healthcare investment throughout his career, beginning at Chase...
Sven H Borho Since 01-Apr-1995
Sven H. Borho, CFA, is a founding General Partner of OrbiMed. Mr. Borho is a portfolio manager for OrbiMed's public...
Samuel D Isaly
Samuel D. Isaly has been active in international and healthcare investment throughout his career, beginning at Chase Manhattan Bank. He studied international economics,...
Sven H Borho
Sven H. Borho, CFA, is a founding General Partner of OrbiMed. Mr. Borho is a portfolio manager for OrbiMed's public equity funds and he heads the firm's trading efforts....
Top performing funds
Create a custom chart of this fund's performance
Check how your portfolios are currently performing
More performance charts
How does this fund compare against other funds in Biotechnology & Healthcare?
Ranking is for the main unit within the sector
View other funds in this sector
FE Risk scores allow you to see how risky a fund is in comparison with the FTSE
Frostrow Capital LLP, 25 Southampton Buildings, London, WC2A 1AL
0203 043 8889 (Fax Number)0203 008 4910 (Main Number)
Worldwide Healthcare Trust PLC Ord
Risk Score 141
Learn more about FE Risk Scores
View all FE Risk Scores
Annual Management Charges: 0.65% of net assets plus 0.30% of market cap. up to £150m and 0.20% > £150m and 0.125% > £500m plus £57,500;
All prices in Pence Sterling (GBX) unless otherwise specified. Price total return performance figures are calculated using closing mid prices and with net income (dividends) reinvested. NAV total return performance figures are calculated using fully diluted (where applicable) daily estimated NAV figures from Thomson Financial Datastream and with gross income (dividends) reinvested.
You are being transferred to our sister website, Trustnet Direct, where you will be able to complete this transaction.
Proceed to Trustnet Direct
Trustnet mobile website
13:00 | Monday, January 20, 2014
Authorised and Regulated by the Financial Conduct Authority
© Trustnet Limited 2015. All Rights Reserved.
Data supplied in conjunction with Thomson Financial Limited, London Stock Exchange
Plc, StructuredRetailProducts.com and ManorPark.com